New platinum (II) complexes based on schiff bases: synthesis, specification, X-ray structure, ADMET, DFT, molecular docking, and anticancer activity against breast cancer

被引:0
作者
Mahboube Eslami Moghadam
Maryam Hasanzadeh Esfahani
Mahdi Behzad
Samaneh Zolghadri
Nadali Ramezani
Yasaman Azadi
机构
[1] Chemistry & Chemical Engineering Research Center of Iran,Department of Chemistry
[2] Semnan University,Department of Biology, Jahrom Branch
[3] Islamic Azad University,undefined
来源
JBIC Journal of Biological Inorganic Chemistry | 2023年 / 28卷
关键词
Anticancer Pt(II) Schiff base; Molecular docking; Breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:519 / 529
页数:10
相关论文
共 128 条
[1]  
Ndagi U(2017)Metal complexes in cancer therapy - an update from drug design perspective Drug Des Dev Ther 11 599-616
[2]  
Mhlongo N(2021)Two new oral candidates as anticancer platinum complexes of 1,3-dimethyl pentyl glycine ligand as doping agents against breast cancer Spect Acta A Mol Biomol Spectrosc. 251 119415-6653
[3]  
Soliman ME(2018)The side effects of platinum-based chemotherapy drugs: a review for chemists Dalton Trans 47 6645-10
[4]  
Ramezani N(2017)Schiff’s bases metal complexes in biological applications J Anal Pharm Res 5 00127-98
[5]  
Eslami Moghadam M(2017)Synthesis of new Schiff base ligand and its complexes in the presence of some transition metal ion and evaluation of their antibacterial properties Med Lab J 11 5-2557
[6]  
Behzad M(2008)Antibacterial and antifungal studies on some schiff base complexes of zinc(II) Mycobiology 36 93-1721
[7]  
Zolghadri S(2020)Preparation, characterization, antioxidant properties of novel Schiff bases including 5-chloroisatin-thiocarbohydrazone Res Chem Intermed 46 2541-1917
[8]  
Oun R(2019)Metal complexes used as anti-inflammatory agents: synthesis, characterization and anti-inflammatory action of VO(II)-complexes Arab J Chem 12 1715-23052
[9]  
Moussa YE(2020)Schiff bases and complexes: a review on anti-cancer activity Anti Agents Med Chem 20 1908-1795
[10]  
Wheate NJ(2019)Synthesis and antibacterial and antiviral activities of myricetin derivatives containing a 1,2,4-triazole Schiff base RSC Adv 9 23045-4245